Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2–) breast cancer is the most common molecular subtype among older patients and those with advanced/metastatic breast cancer (a/mBC). Here, ERBB2 is linked to breast cancer.